TY - JOUR
T1 - Reproductive Life Stages and Female Sex-Specific Patterns in Uveitis Activity
T2 - Data From the AIDA Network Uveitis Registry
AU - GAGGIANO, CARLA
AU - DE-LA-TORRE, ALEJANDRA
AU - GUERRIERO, SILVANA
AU - TIERRADENTRO-ALAPE, RAFAEL
AU - RAGAB, GAAFAR
AU - FORERO-URIBE, ANGIE
AU - COSTI, STEFANIA
AU - DAMMACCO, ROSANNA
AU - PAROLI, MARIA PIA
AU - HEGAZY, MOHAMED THARWAT
AU - DEL GIUDICE, EMANUELA
AU - SOTA, JURGEN
AU - HINOJOSA-AZAOLA, ANDREA
AU - BREDA, LUCIANA
AU - VITALE, ANTONIO
AU - FONOLLOSA, A. L.E.X.
AU - CIVINO, ADELE
AU - GENTILESCHI, STEFANO
AU - CATTALINI, MARCO
AU - MAURO, ANGELA
AU - CAGGIANO, VALERIA
AU - HASHAD, S. O.A.D.
AU - SBALCHIERO, JESSICA
AU - RUSCITTI, PIERO
AU - CHIMENTI, MARIA SOLE
AU - TARSIA, MARIA
AU - GIARDINI, HENRIQUE AYRES MAYRINK
AU - CONFORTI, ALESSANDRO
AU - THARWAT, SAMAR
AU - CARUBBI, FRANCESCO
AU - MOSHRIF, ABDELHAFEEZ
AU - HERNÁNDEZ-RODRÍGUEZ, J. O.S.É.
AU - FOTIS, LAMPROS
AU - BUGATTI, SERENA
AU - AL-MAYOUF, SULAIMAN
AU - KARAMANAKOS, ANASTASIOS
AU - PIGA, MATTEO
AU - MINOIA, FRANCESCA
AU - MAGGIO, MARIA CRISTINA
AU - SEBASTIANI, GIAN DOMENICO
AU - CONTI, GIOVANNI
AU - BARONE, PATRIZIA
AU - KAWAKAMI-CAMPOS, PERLA AYUMI
AU - LOPALCO, GIUSEPPE
AU - LA TORRE, FRANCESCO
AU - GICCHINO, MARIA FRANCESCA
AU - OZEN, S. E.Z.A.
AU - BATU, EZGI DENIZ
AU - FREDIANI, BRUNO
AU - CANTARINI, L. U.C.A.
AU - FABIANI, CLAUDIA
N1 - Publisher Copyright:
© 2025 The Author(s)
PY - 2026/2
Y1 - 2026/2
N2 - OBJECTIVE OR PURPOSE: To investigate whether noninfectious uveitis (NIU) activity varies across reproductive life stages (RLS) according to sex. DESIGN: Observational, retrospective, cross-sectional registry-based study. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: The study recruited female patients with NIU (regardless of anatomical location or underlying etiology) as the main study group and male patients as controls to allow sex-based comparisons. They were enrolled in the AIDA Network Uveitis Registry between 2020 and 2025. METHODS, INTERVENTION, OR TESTING: RLS (prepuberal, early puberty, late puberty, reproductive, perimenopause, and podtmenopausal) were approximated using age intervals derived from epidemiological data. Study outcomes were flare frequency, anterior chamber cells (ACC), anterior chamber flare, vitreous haze, new posterior segment inflammatory signs, and immunosuppressive treatment (IST) exposure. RESULTS: Four hundred twenty-five female and 275 male patients were included. Median (IQR) relapse number in 12 months was 0.8 (1.3) [min 0.0-max 2.0] in prepuberty, 1.0 (2.0) [0.0-5.0] in early puberty, 0.0 (1.0) [0.0-5.0] in late puberty, 0.5 (1.0) [0.0-8.0] in reproductive age, 1.0 (1.0) [0.0-10.0] in perimenopause, and 0.5 (1.0) [0.0-7.5] in post-menopause (P =. 014). There was a statistically significant interaction between RLS and sex (P =. 044), with a perimenopausal peak retained only in women. In subjects with active anterior involvement, differences in the distribution of ACC grades among RLS were observed, with a peak in prepuberty and early puberty (P =. 004). Proportions of subjects receiving IST were higher in prepuberty and puberty than in the remaining RLS (P =. 012). CONCLUSIONS: RLS are clinically relevant modifiers of uveitis activity and should guide patient education, risk stratification, and therapy. Early puberty and perimenopause increase relapse risk; pediatric cases show more severe anterior inflammation and require more systemic IST.
AB - OBJECTIVE OR PURPOSE: To investigate whether noninfectious uveitis (NIU) activity varies across reproductive life stages (RLS) according to sex. DESIGN: Observational, retrospective, cross-sectional registry-based study. SUBJECTS, PARTICIPANTS, AND/OR CONTROLS: The study recruited female patients with NIU (regardless of anatomical location or underlying etiology) as the main study group and male patients as controls to allow sex-based comparisons. They were enrolled in the AIDA Network Uveitis Registry between 2020 and 2025. METHODS, INTERVENTION, OR TESTING: RLS (prepuberal, early puberty, late puberty, reproductive, perimenopause, and podtmenopausal) were approximated using age intervals derived from epidemiological data. Study outcomes were flare frequency, anterior chamber cells (ACC), anterior chamber flare, vitreous haze, new posterior segment inflammatory signs, and immunosuppressive treatment (IST) exposure. RESULTS: Four hundred twenty-five female and 275 male patients were included. Median (IQR) relapse number in 12 months was 0.8 (1.3) [min 0.0-max 2.0] in prepuberty, 1.0 (2.0) [0.0-5.0] in early puberty, 0.0 (1.0) [0.0-5.0] in late puberty, 0.5 (1.0) [0.0-8.0] in reproductive age, 1.0 (1.0) [0.0-10.0] in perimenopause, and 0.5 (1.0) [0.0-7.5] in post-menopause (P =. 014). There was a statistically significant interaction between RLS and sex (P =. 044), with a perimenopausal peak retained only in women. In subjects with active anterior involvement, differences in the distribution of ACC grades among RLS were observed, with a peak in prepuberty and early puberty (P =. 004). Proportions of subjects receiving IST were higher in prepuberty and puberty than in the remaining RLS (P =. 012). CONCLUSIONS: RLS are clinically relevant modifiers of uveitis activity and should guide patient education, risk stratification, and therapy. Early puberty and perimenopause increase relapse risk; pediatric cases show more severe anterior inflammation and require more systemic IST.
UR - https://www.scopus.com/pages/publications/105024240442
UR - https://www.scopus.com/pages/publications/105024240442#tab=citedBy
U2 - 10.1016/j.ajo.2025.11.009
DO - 10.1016/j.ajo.2025.11.009
M3 - Research Article
C2 - 41242592
AN - SCOPUS:105024240442
SN - 0002-9394
VL - 282
SP - 292
EP - 304
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
ER -